ARQT
#1590
Arcutis Biotherapeutics, Inc. - Common stock
26.2 2 USD
-0.01%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-1.35%
Variación mensual
+9.02%
Variación en los últimos 6 meses
+7.90%
Cambio anual
+27.96%
Cierres anteriores
26.5 8
Open
26.5 4
Mínimo
25.9 7
Máximo
26.8 2
Financials
- Market Capitalization 3.3 B
- Employee 354
- Founded 2016
- CEO Frank Watanabe
- Website www.arcutis.com
- Headquarter Delaware, United States
- FIGI BBG00QN8K4M4
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-223.38
Relación precio/flujo de caja
9.82
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 1581 |  ACAD ACADIA Pharmaceuticals Inc. - Common Stock | 19.41 USD | -1.87% | -3.72% | -30.70% | -1.87% | 3.34 B USD | ||
| 1586 |  VKTX Viking Therapeutics, Inc. - Common Stock | 28.34 USD | -0.60% | -3.87% | -10.60% | -13.76% | 3.31 B USD | ||
| 1592 |  LEGN Legend Biotech Corporation - American Depositary Shares | 17.80 USD | -4.40% | -6.32% | -5.32% | -44.34% | 3.29 B USD | ||
| 1600 |  TARS Tarsus Pharmaceuticals, Inc. - Common Stock | 74.40 USD | +1.69% | -0.11% | -6.64% | +12.62% | 3.26 B USD |